TURKISH JOURNAL OF PATHOLOGY, vol.34, no.3, pp.199-206, 2018 (ESCI, Scopus, TRDizin)
Objective: Although classical Hodgkin lymphoma (c H L) has a relatively good prognosis, it also entails different treatment responses and involves patients who have different clinical courses. Our aim was to investigate c-Myc, Bcl-2 and EBV biomarkers in cHL and their relationship with the IPS score.